Wen‐Wei Chang

3.4k total citations
77 papers, 2.6k citations indexed

About

Wen‐Wei Chang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wen‐Wei Chang has authored 77 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 19 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Wen‐Wei Chang's work include Cancer Cells and Metastasis (13 papers), Nanoplatforms for cancer theranostics (9 papers) and Cancer Research and Treatments (9 papers). Wen‐Wei Chang is often cited by papers focused on Cancer Cells and Metastasis (13 papers), Nanoplatforms for cancer theranostics (9 papers) and Cancer Research and Treatments (9 papers). Wen‐Wei Chang collaborates with scholars based in Taiwan, United States and Japan. Wen‐Wei Chang's co-authors include Che‐Hsin Lee, Cheng‐Chia Yu, Bing‐Yen Wang, Alice L. Yu, Wenya Huang, Ih‐Jen Su, Hsueh‐Te Lee, Yueh‐Chun Lee, Peng‐Ju Chien and Jyh‐Cherng Yu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Hepatology and Cancer Research.

In The Last Decade

Wen‐Wei Chang

75 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen‐Wei Chang Taiwan 31 1.3k 538 420 315 309 77 2.6k
Xiaojuan Yang China 27 1.6k 1.2× 607 1.1× 555 1.3× 318 1.0× 151 0.5× 81 3.0k
Bikul Das United States 23 1.6k 1.2× 922 1.7× 628 1.5× 391 1.2× 231 0.7× 54 3.3k
Ernesto Yagüe United Kingdom 30 1.6k 1.2× 830 1.5× 632 1.5× 216 0.7× 138 0.4× 60 2.5k
Kevin Dzobo South Africa 27 1.1k 0.9× 710 1.3× 439 1.0× 595 1.9× 122 0.4× 53 3.2k
Yili Wang China 27 862 0.7× 690 1.3× 368 0.9× 164 0.5× 335 1.1× 121 2.7k
Prabhudas S. Patel India 28 1.5k 1.1× 558 1.0× 571 1.4× 163 0.5× 143 0.5× 135 2.8k
Qianqian Zhu China 35 1.9k 1.5× 437 0.8× 938 2.2× 306 1.0× 458 1.5× 159 3.9k
Ningyan Zhang United States 37 1.8k 1.4× 1.1k 2.1× 338 0.8× 304 1.0× 634 2.1× 122 4.7k

Countries citing papers authored by Wen‐Wei Chang

Since Specialization
Citations

This map shows the geographic impact of Wen‐Wei Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Wei Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Wei Chang more than expected).

Fields of papers citing papers by Wen‐Wei Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Wei Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Wei Chang. The network helps show where Wen‐Wei Chang may publish in the future.

Co-authorship network of co-authors of Wen‐Wei Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Wei Chang. A scholar is included among the top collaborators of Wen‐Wei Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Wei Chang. Wen‐Wei Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Chun‐Yu, et al.. (2024). Ovatodiolide inhibits endometrial cancer stemness via reactive oxygen species-mediated DNA damage and cell cycle arrest. Chemico-Biological Interactions. 403. 111244–111244. 3 indexed citations
3.
Chen, I‐Hui, Wan-Hua Tsai, Tzong-Yi Lee, et al.. (2024). The impact of Lacticaseibacillus paracasei GMNL-143 toothpaste on gingivitis and oral microbiota in adults: a randomized, double-blind, crossover, placebo-controlled trial. BMC Oral Health. 24(1). 477–477. 5 indexed citations
4.
Yen, W.L., et al.. (2023). Salmonella inhibits tumor metastasis by downregulating epithelial cell adhesion molecules through the protein kinase-B/mammalian target of rapamycin signaling pathway. International Journal of Biological Macromolecules. 253(Pt 3). 126913–126913. 4 indexed citations
6.
Fang, Yi‐Ting, et al.. (2023). Heat-killed Lacticaseibacillus paracasei GMNL-653 ameliorates human scalp health by regulating scalp microbiome. BMC Microbiology. 23(1). 121–121. 13 indexed citations
7.
Chang, Wen‐Wei, Ying‐Hsiang Chou, Jing‐Yang Huang, et al.. (2023). Effectiveness of multimedia courses in improving self-care among patients with breast cancer undergoing radiotherapy. Radiation Oncology. 18(1). 115–115. 4 indexed citations
9.
Wang, Bing‐Yen, et al.. (2020). Targeted photoresponsive carbazole–coumarin and drug conjugates for efficient combination therapy in leukemia cancer cells. Bioorganic Chemistry. 100. 103904–103904. 20 indexed citations
10.
Chang, Wen‐Wei, et al.. (2019). Glucose Transporter 3 Is Essential for the Survival of Breast Cancer Cells in the Brain. Cells. 8(12). 1568–1568. 35 indexed citations
11.
Chen, Yi‐Hsing, Wen‐Ling Yeh, Ya-Hui Chen, et al.. (2019). Probiotic Lactobacillus spp. Act Against Helicobacter pylori-induced Inflammation. Journal of Clinical Medicine. 8(1). 90–90. 90 indexed citations
12.
Wattanakul, Karnthidaporn, et al.. (2019). Oligopeptide-side chained alginate nanocarrier for melittin-targeted chemotherapy. Polymer Journal. 51(8). 771–780. 12 indexed citations
13.
Yang, Chih‐Jen, et al.. (2018). Salmonella Overcomes Drug Resistance in Tumor through P-glycoprotein Downregulation. International Journal of Medical Sciences. 15(6). 574–579. 30 indexed citations
14.
Hsieh, Ming‐Chia, Wan-Hua Tsai, Shih‐Li Su, et al.. (2018). The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial. Scientific Reports. 8(1). 16791–16791. 138 indexed citations
15.
Yang, Chih‐Jen, et al.. (2017). The inhibition of indoleamine 2, 3-dioxygenase 1 by connexin 43. International Journal of Medical Sciences. 14(12). 1181–1188. 28 indexed citations
17.
Wu, Shey‐Lin, Ming‐Shiun Tsai, Gunn‐Guang Liou, et al.. (2014). Double homeobox gene, Duxbl, promotes myoblast proliferation and abolishes myoblast differentiation by blocking MyoD transactivation. Cell and Tissue Research. 358(2). 551–566. 9 indexed citations
18.
Chang, Wen‐Wei, Ih Jen Su, Ming‐Chih Lai, et al.. (2008). Suppression of p38 mitogen-activated protein kinase inhibits hepatitis B virus replication in human hepatoma cell: the antiviral role of nitric oxide. Journal of Viral Hepatitis. no–no. 14 indexed citations
19.
Hsieh, Yi‐Hsuan, Ih‐Jen Su, Huan-Yao Lei, et al.. (2007). Differential endoplasmic reticulum stress signaling pathways mediated by iNOS. Biochemical and Biophysical Research Communications. 359(3). 643–648. 31 indexed citations
20.
Chang, Wen‐Wei, Ih‐Jen Su, Ming-Derg Lai, et al.. (2003). The role of inducible nitric oxide synthase in a murine acute hepatitis B virus (HBV) infection model induced by hydrodynamics-based in vivo transfection of HBV-DNA. Journal of Hepatology. 39(5). 834–842. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026